Analyst Sees Affymax's (AFFY) Omontys as Comparable to Amgen's (AMGN) Epogen; Raises AFFY Target to $21
Go back to Analyst Sees Affymax's (AFFY) Omontys as Comparable to Amgen's (AMGN) Epogen; Raises AFFY Target to $21| Affymax, Inc. (AMEX: AFFY) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.11 | |||
| Open | $0.00 | 52 Week Low | $0.05 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-4.15 | |||
| Volume | 50,156,274 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 439.33 +5.60 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $433.73 | 52 Week High | $176.85 | |||
| Open | $431.72 | 52 Week Low | $133.64 | |||
| Day High | $440.51 | P/E | 66.16 | |||
| Day Low | $429.38 | EPS | $6.64 | |||
| Volume | 2,114,678 | |||||
